Illumina Hit With Derivative Suit Over $6.6B Stock Drop
A shareholder of genetic research firm Illumina Inc. hit the company's directors with a derivative suit late Monday in Delaware Chancery Court accusing them of breaching their fiduciary duties by making...To view the full article, register now.
Already a subscriber? Click here to view full article